The association between hospital volume and overall survival in adult AML patients treated with intensive chemotherapy.

Saved in:
Bibliographic Details
Title: The association between hospital volume and overall survival in adult AML patients treated with intensive chemotherapy.
Authors: Kaplan ZLR; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands. Electronic address: z.kaplan@erasmusmc.nl., van Leeuwen N; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., van Klaveren D; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Eijkenaar F; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands., Visser O; Department of Registration, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands., Posthuma EFM; Department of Internal Medicine, Reinier de Graaf Hospital, Delft, The Netherlands; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Zweegman S; Department of Hematology, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands., Huls G; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., van Rhenen A; Department of Hematology, Utrecht University Medical Center, Utrecht, The Netherlands., Blijlevens NMA; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Cornelissen JJ; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., van de Loosdrecht AA; Department of Hematology, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands., Pruijt JHFM; Department of Internal Medicine, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands., Hoogendoorn M; Department of Internal Medicine, Medical Centre Leeuwarden, Leeuwarden, The Netherlands., Lemmens VEPP; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands., Lingsma HF; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Dinmohamed AG; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
Source: ESMO open [ESMO Open] 2025 Feb; Vol. 10 (2), pp. 104152. Date of Electronic Publication: 2025 Jan 30.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2059-7029
DOI:10.1016/j.esmoop.2025.104152